AXL and melanoma: In addition to its role in melanoma invasion and migration, AXL has been shown to promote both intrinsic and acquired resistance to chemotherapeutic, immunotherapeutic, and molecularly targeted therapies both in solid and hematologic malignancies [54,65]).